These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11952137)

  • 1. Encephalomyocarditis and Mengo viruses productively infect murine T-lymphocyte cell lines but not fresh ex vivo derived T lymphocytes.
    Neal ZC; Harms JS; Hill MR; Splitter GA
    Viral Immunol; 2002; 15(1):155-63. PubMed ID: 11952137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies.
    Neal ZC; Splitter GA
    J Virol; 1998 Oct; 72(10):8052-60. PubMed ID: 9733845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of endogenous viral polymerase, 3D(pol), in preparations of Mengo and encephalomyocarditis viruses.
    Frolov VG; Duque H; Palmenberg AC
    Virology; 1999 Jul; 260(1):148-55. PubMed ID: 10405366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture.
    Martin LR; Neal ZC; McBride MS; Palmenberg AC
    J Virol; 2000 Apr; 74(7):3074-81. PubMed ID: 10708422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus.
    Osorio JE; Hubbard GB; Soike KF; Girard M; van der Werf S; Moulin JC; Palmenberg AC
    Vaccine; 1996 Feb; 14(2):155-61. PubMed ID: 8852413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cell response to Mengo virus in mice: effector cell phenotype and target proteins.
    Escriou N; Leclerc C; Gerbard S; Giraud M; van der Werf S
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1999-2007. PubMed ID: 7636480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell microfilaments disorganization is an early cytopathic effect in mengo virus replication.
    Rubino S; Monaco A; Degener A; Cappuccinelli P
    Microbiologica; 1991 Apr; 14(2):95-102. PubMed ID: 1649961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies.
    Neal ZC; Splitter GA
    J Virol; 1995 Aug; 69(8):4914-23. PubMed ID: 7609060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Mengo virus T helper cell epitopes.
    Muir S; Kobasa D; Bittle J; Scraba D
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2925-36. PubMed ID: 7525861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-induced diabetes mellitus: mengovirus infects pancreatic beta cells in strains of mice resistant to the diabetogenic effect of encephalomyocarditis virus.
    Yoon JW; Morishima T; McClintock PR; Austin M; Notkins AL
    J Virol; 1984 Jun; 50(3):684-90. PubMed ID: 6327999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells.
    Yeung MC; Chang DL; Camantigue RE; Lau AS
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11860-5. PubMed ID: 10518541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenic and pathogenic potential of short poly(C) tract Mengo viruses.
    Osorio JE; Martin LR; Palmenberg AC
    Virology; 1996 Sep; 223(2):344-50. PubMed ID: 8806569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts.
    Hahn H; Palmenberg AC
    J Virol; 1995 Apr; 69(4):2697-9. PubMed ID: 7884926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection.
    Bazzone LE; King M; MacKay CR; Kyawe PP; Meraner P; Lindstrom D; Rojas-Quintero J; Owen CA; Wang JP; Brass AL; Kurt-Jones EA; Finberg RW
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of adenovirus-mediated small interfering RNAs against encephalomyocarditis virus challenge in mice.
    Bai J; Jiang K; Zhang L; Wang X; Wang X; Li Y; Jiang P
    J Virol Methods; 2012 Nov; 185(2):204-12. PubMed ID: 22790206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOME PROPERTIES OF THE ENCEPHALOMYOCARDITIS, COLUMBIA SK AND MENGO VIRUSES.
    CRAIGHEAD JE
    Proc Soc Exp Biol Med; 1965 Jun; 119():408-12. PubMed ID: 14328905
    [No Abstract]   [Full Text] [Related]  

  • 18. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus.
    Exley MA; Bigley NJ; Cheng O; Tahir SM; Smiley ST; Carter QL; Stills HF; Grusby MJ; Koezuka Y; Taniguchi M; Balk SP
    J Leukoc Biol; 2001 May; 69(5):713-8. PubMed ID: 11358978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplanting encephalomyocarditis virus-infected porcine islet cells reverses diabetes in recipient mice but also transmits the virus.
    Brewer L; LaRue R; Hering B; Brown C; Njenga MK
    Xenotransplantation; 2004 Mar; 11(2):160-70. PubMed ID: 14962278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichomonas vaginalis resistance to Mengo virus infection.
    Eva A; Viano I; Martinotti MG; Cappuccinelli P
    J Protozool; 1979 May; 26(2):249-52. PubMed ID: 226694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.